Symbol="ETNB"
AssetType="Common Stock"
Name="89bio Inc"
Description="89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardiometabolic diseases. The company is headquartered in San Francisco, California."
CIK="1785173"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="535 MISSION STREET, 14TH FLOOR, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1414377000"
EBITDA="-105604000"
PERatio="None"
PEGRatio="None"
BookValue="6.12"
DividendPerShare="0"
DividendYield="0"
EPS="-2.31"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.21"
ReturnOnEquityTTM="-0.384"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.31"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="37.44"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.111"
EVToRevenue="-"
EVToEBITDA="-2.924"
Beta="0.754"
num_52WeekHigh="22.93"
num_52WeekLow="3.17"
num_50DayMovingAverage="18.37"
num_200DayMovingAverage="13.01"
SharesOutstanding="72868000"
DividendDate="None"
ExDividendDate="None"
symbol="ETNB"
open="19.52"
high="19.59"
low="18.53"
price="18.79"
volume="1333514.00"
latest_trading_day="2023-07-11"
previous_close="19.41"
change="-0.62"
change_percent="-3.1942%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="1981700"
Change_recent_avg="-0.01"
Delta_recent_avg="1.1"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="-0.23"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_negative_thumbnail_id_2="1119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0152.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="1166"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_positive_thumbnail_id_2="672"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
